Editorial
McMullen et al 1 have reported their experience with minimal margin extracapsular dissection of benign parotid tumors. The authors examine their results pertaining to 40 patients who underwent a minimal margin resection of a benign parotid tumor, although 2 cases turned out to be malignant. The results consist of 1 case of temporary facial nerve weakness, no cases of Frey syndrome, and no tumor recurrences, with an average follow-up of 3½ years.
It is notable that the tumor for which recurrence is most likely and problematic, pleomorphic adenoma, comprised 20 of the 40 total cases. Therefore, it is these 20 cases that are of greatest interest as it is unlikely to be problematic to perform minimal margin excisions of (for example) Warthin's tumors. The authors report no tumor recurrences and 1 episode of temporary weakness in the marginal mandibular nerve.
While the authors demonstrate reasonable safety metrics with regard to minimal margin excision, it must be emphasized that this is a case series without an appropriate comparison or control group. Thus, we do not know if extracapsular dissection or superficial parotidectomy would have resulted in similar results if performed by the same group of surgeons. Witt 2 published a study comparing total parotidectomy, superficial parotidectomy, and extracapsular dissection in the management of pleomorphic adenoma. Although the cases in this study were not performed by a single surgeon, the data revealed that focal capsular exposure occurred in most every case regardless of approach. However, this capsular exposure is most often focal and not involving the entire tumor. It is not clear that an extrapolation of this, namely, exposure of the entire capsule, is therefore safe with regard to recurrence as McMullen et al 1 With regard to facial nerve outcomes, Witt 2 reported a lower rate of transient facial nerve paralysis in patients receiving extracapsular dissections (0/20, 0%) compared to those receiving superficial parotidectomy (4/20, 20%). This supports the theory that routine dissection of the facial nerve (ie, superficial parotidectomy) will result in higher rates of transient paralysis when compared to extracapsular dissection that does not routinely expose the nerve. The article (Klintworth et al 3 ) quoted by the authors with regard to complications associated with extracapsular dissection described a complication rate that is on the high end of that seen in the literature. Klintworth et al 3 reported 6% temporary paresis (an additional 2% had a HB II/III permanent paresis) versus 0% as reported by Witt, 2 albeit in a much smaller sample. Given that McMullen et al 1 report a single case in which the marginal branch of the facial nerve was temporarily paretic (although the nerve was not visualized), it is certainly possible to traumatize the facial nerve in minimal margin dissection. Therefore, it is reasonable to carefully deliberate the benefits of minimal margin excision compared to extracapsular dissection.
Each surgeon must ask themselves the fundamental question of why they might choose to do a minimal margin dissection when extracapsular dissection seems to have a growing body of literature supporting its safety with regard to facial nerve outcomes and risk of recurrence. McMullen et al 1 have provided preliminary data that minimal margin dissection may be safe in experienced hands based on a small sample. However, for most surgeons performing parotidectomy (and especially those who perform it only occasionally), the much larger body of evidence supporting the use of superficial parotidectomy or extracapsular dissection must be strongly considered until additional data can confirm their findings through the use of larger studies and comparison groups. In this way, the outcomes associated with minimal margin excision of benign parotid tumors can be more rigorously assessed. Samir S. Khariwala, MD, MS, FACS
